Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Patel Anish. Director active across 1 company, notably Enliven Therapeutics, Inc.. Aggregated, 19 reports have been published. Breakdown: 0 buy · 12 sells. Total volume traded: €1.2m. History available since 22 December 2023. The latest transaction was disclosed on 7 May 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations19 total
6,173 shares@ US$18.29698.0% of flowCommon StockSEC:0001415889-25-012591:0
3,756 shares@ US$17.80874.9% of flowCommon StockSEC:0001415889-25-010474:0
6,667 shares@ US$21.439410.6% of flowCommon StockSEC:0001415889-25-007683:0
6,667 shares@ US$21.929811.3% of flowCommon StockSEC:0001415889-25-003515:0
10,700 shares@ US$1.120.9% of flowCommon StockSEC:0001415889-25-001301:0
716 shares@ US$30.00351.6% of flowCommon StockSEC:0001415889-24-025505:0
17,475 shares@ US$25.069832.3% of flowCommon StockSEC:0001415889-24-019600:0
1,133 shares@ US$2.480.2% of flowCommon StockSEC:0001415889-24-016279:0
1,107 shares@ US$2.480.2% of flowCommon StockSEC:0001415889-24-013383:0
260 shares@ US$2.480.0% of flowCommon StockSEC:0001415889-24-013071:0
4,875 shares@ US$2.480.9% of flowCommon StockSEC:0001415889-24-012652:0
14,903 shares@ US$2.482.8% of flowCommon StockSEC:0001415889-24-010831:0
4,331 shares@ US$18.50255.9% of flowCommon StockSEC:0001415889-24-010676:0
4,875 shares@ US$15.63875.6% of flowCommon StockSEC:0001415889-24-007457:0
4,875 shares@ US$15.10945.5% of flowCommon StockSEC:0001415889-24-003122:0
4,875 shares@ US$15.1355.4% of flowCommon StockSEC:0001209191-24-002190:0
2,520 shares@ US$15.07762.7% of flowCommon StockSEC:0001209191-24-000256:0
983 shares@ US$15.03131.1% of flowCommon StockSEC:0001209191-23-059816:0
36,722 sharesCommon StockSEC:0001209191-23-013496:0